J&J Launches Incubator for Biotechs in San Diego, No Strings-Attached Business Model
Incubators run by universities and economic development groups have long provided the facilities, expertise and even funding to help biotechs bridge the valley of death. But incubators run by drug companies have garnered mixed results.
From Seeking Alpha:
“Johnson & Johnson (JNJ) [has announced] the launch of Janssen Labs at San Diego, a 30,000-square-foot incubator designed to serve as the future home for 18 to 20 biotech start-ups.
Companies in the J&J incubator will get access to their own space, as well as common areas that house equipment for nuclear magnetic resonance, mass spectrometry, flow cytometry and other analyses. In exchange for short, renewable leases, they will get “cost-efficient, flexible, turnkey wet labs…”
READ FULL ARTICLE [web]